The phytochemicals plant at Sanmar Speciality Chemicals, Berikai, which manufactures bulk drugs, was certified by the Directorate of Drugs Control for conformance to the requirements of Good Manufacturing Practices (GMP) under the norms of the World Health Organisation (WHO). After carrying out a compliance audit in January 2001, the central and the state drug control authorities awarded the certificate to SSCL. The phytochemicals facility was also audited for cGMP (current Good Manufacturing Practices) by Welding GmbH, Germany in March 2001 and by Sagriv, France (representing Wyeth Ayerst Laboratories) in April 2001. The two are important customers for active pharmaceutical ingredients manufactured at this facility.
V R Venkataraman, Vice-President-Operations, clarifying a point to Pierre Sagaut, Managing Director, Sagriv and Pierre Magnet of Macopharmi, France, during the cGMP audit.
Dr Petra Zubiller from Welding GmbH, Germany,
conducting a cGMP audit.